Harvard Apparatus Regenerative Technology, Inc. (HRGN) Free cash flow 2016–2024
Harvard Apparatus Regenerative Technology, Inc. (HRGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.9MFY2024 · since FY2016: -$9.4M → -$4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$4.9M | +30.2% |
| FY2023 | -$7.0M | -36.0% |
| FY2022 | -$5.1M | -94.5% |
| FY2021 | -$2.6M | +35.1% |
| FY2020 | -$4.0M | +34.6% |
| FY2019 | -$6.2M | +20.4% |
| FY2018 | -$7.8M | +30.3% |
| FY2017 | -$11.2M | -19.1% |
| FY2016 | -$9.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More HRGN financial trends
HRGN RevenueHRGN Net incomeHRGN Net marginHRGN Gross profitHRGN Gross marginHRGN Operating incomeHRGN Operating marginHRGN Operating cash flowHRGN Capital expendituresHRGN Return on equityHRGN Stock buybacksHRGN Dividends paidHRGN Total assetsHRGN Total liabilitiesHRGN Shareholders’ equityHRGN overview →